Cobra Expansion Video Blog

21st April 2017 | General

As We Embark On A £15m / 165m SEK / $19m Gene Therapy Manufacturing Operations Expansion

Following the news of Cobra's expansion earlier this week, Chief Executive Peter Coleman took to social media to express his gratitude for the fantastic response we have recieved and to highlight the importance of investing in gene therapy:

Chief Scientific Officer, Dr Daniel Smith also uploaded his thoughts:

Follow Cobra on Twitter for the latest updates: @CobraBiologics
comments powered by Disqus
In order to provide complete functionality, this web site needs your explicit consent to store browser cookies. If you don't allow cookies, you may not be able to use certain features of the web site. It is recommended that you allow all cookies. Allow all cookies